Drawing for SALUSMED

USPTO serial 79000395

SALUSMED

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
FINE, STEVEN
Law office
TMO LAW OFFICE 110 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SALUSMED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB666 3RD AVE 10TH FLNEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044Analysis of the status of vital substances in the body, namely, antioxidants, vitamins and trace elements, and preparation of a personally tailored supplement mixture to address any deficienciesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 29, 2023RNWLINTERNATIONAL REGISTRATION RENEWED—
Dec 21, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 20, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 27, 2022RFNTREFUSAL PROCESSED BY IB—
Jul 5, 2014DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jul 4, 2014DETHDEATH OF INTERNATIONAL REGISTRATION—
Dec 6, 2007ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 1, 2006FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
May 17, 2006FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 16, 2006FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 28, 2005OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 25, 2005MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 25, 2005ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 7, 2005OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 7, 2005OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 27, 2004CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 24, 2004CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 2, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 19, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 19, 2004MAILPAPER RECEIVED—
Sep 9, 2004RFNTREFUSAL PROCESSED BY IB—
Jul 22, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 6, 2004DOCKASSIGNED TO EXAMINER—
Feb 13, 2004NWAPNEW APPLICATION ENTERED—
Feb 9, 2004REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance